TARS - Tarsus Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TARS is currently covered by 6 analysts with an average price target of $91.38. This is a potential upside of $23.86 (35.34%) from yesterday's end of day stock price of $67.52.

Tarsus Pharmaceuticals 's activity chart (see below) currently has 52 price targets and 42 ratings on display. The stock rating distribution of TARS is 81.82% BUY and 18.18% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 96.88% with an average time for these price targets to be met of 513 days.

Highest price target for TARS is $84, Lowest price target is $51, average price target is $66.33.

Most recent stock forecast was given by ANDREA TAN from GOLDMAN SACHS on 04-May-2025. First documented stock forecast 09-Nov-2020.

Currently out of the existing stock ratings of TARS, 9 are a BUY (81.82%), 2 are a HOLD (18.18%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$51

$-15.06 (-22.80%)

$41

5 months 26 days ago
(04-May-2025)

4/4 (100%)

$3 (6.25%)

87

Buy

$84

$17.94 (27.16%)

5 months 29 days ago
(01-May-2025)

3/4 (75%)

$36.64 (77.36%)

457

Buy

$58

$-8.06 (-12.20%)

$45

7 months 25 days ago
(05-Mar-2025)

3/3 (100%)

$14.43 (33.12%)

477

Buy

$73

$6.94 (10.51%)

$61

8 months 5 days ago
(25-Feb-2025)

10/10 (100%)

$30.44 (71.52%)

564

Buy

$60

$-6.06 (-9.17%)

$62

8 months 5 days ago
(25-Feb-2025)

5/5 (100%)

$17.44 (40.98%)

415

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TARS (Tarsus Pharmaceuticals ) average time for price targets to be met?

On average it took 513 days on average for the stock forecasts to be realized with a an average price target met ratio 96.88

Which analyst has the current highest performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the current lower performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?

ANDREA TAN

Which analyst has the most public recommendations on TARS (Tarsus Pharmaceuticals )?

Francois Brisebois works at OPPENHEIMER and has 3 price targets and 2 ratings on TARS

Which analyst is the currently most bullish on TARS (Tarsus Pharmaceuticals )?

Eddie Hickman with highest potential upside - $17.94

Which analyst is the currently most reserved on TARS (Tarsus Pharmaceuticals )?

Andrea Tan with lowest potential downside - -$15.06

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?